These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3265476)

  • 1. Targeted cytotoxic cells as a novel form of cancer immunotherapy.
    Segal DM; Garrido MA; Perez P; Titus JA; Winkler DA; Ring DB; Kaubisch A; Wunderlich JR
    Mol Immunol; 1988 Nov; 25(11):1099-103. PubMed ID: 3265476
    [No Abstract]   [Full Text] [Related]  

  • 2. [New era of tumor immunotherapy].
    Yoshitake Y; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting of cytotoxic cells against tumors with heterocrosslinked, bispecific antibodies.
    Segal DM; Qian JH; Garrido MA; Perez P; Winkler DF; Wunderlich JR; Snider DP; Valdayo MJ; Titus JA
    Princess Takamatsu Symp; 1988; 19():323-31. PubMed ID: 3269363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural cytotoxic cells (NK cells)].
    Frydecka I
    Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1343-5. PubMed ID: 6371740
    [No Abstract]   [Full Text] [Related]  

  • 5. Perforin, killer cells and gene transfer immunotherapy for cancer.
    Podack ER
    Curr Top Microbiol Immunol; 1995; 198():121-30. PubMed ID: 7774277
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells.
    Santin AD; Bellone S; Ravaggi A; Pecorelli S; Cannon MJ; Parham GP
    Obstet Gynecol; 2000 Sep; 96(3):422-30. PubMed ID: 10960637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line.
    Sato T; Okubo M; Wada Y; Sato N; Kikuchi K
    Jpn J Cancer Res; 1989 Jul; 80(7):655-61. PubMed ID: 2507488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-tumor effect of cytotoxic T lymphocytes induced by soluble antigen of ovarian carcinoma and anti-CD3 monoclonal antibody on ovarian carcinoma].
    Zhang Q; Wan Y; Zhai H
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):355-7. PubMed ID: 10806675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New insights into cytotoxic effector cells].
    Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
    Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.
    Nakajima F; Khanna A; Xu G; Lagman M; Haschemeyer R; Mouradian J; Wang JC; Stenzel KH; Rubin AL; Suthanthiran M
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7889-93. PubMed ID: 8058730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic lymphocyte-mediated immunotherapy.
    Smyth MJ; Kershaw MH
    Aust N Z J Med; 1995 Dec; 25(6):852-8. PubMed ID: 8770363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes.
    Baxevanis CN; Gritzapis AD; Tsitsilonis OE; Katsoulas HL; Papamichail M
    Int J Cancer; 2002 Apr; 98(6):864-72. PubMed ID: 11948464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of cytotoxic lymphocytes potentially relevant for cellular immunotherapy of cancer: implications for designing clinical strategies.
    Triebel F; Hercend T
    Prog Clin Biol Res; 1987; 244():207-11. PubMed ID: 3498949
    [No Abstract]   [Full Text] [Related]  

  • 15. [Types of cellular antitumor cytotoxicity].
    Lomakin MS; Maĭskiĭ IN
    Vopr Onkol; 1988; 34(12):1422-32. PubMed ID: 2975420
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic lymphocytes.
    Sinkovics JG
    Ann Clin Lab Sci; 1986; 16(6):488-96. PubMed ID: 3492170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytotoxic cells of the NK type - their characteristics and role in anti-neoplastic immunity].
    Janiak M; Lipski S
    Postepy Hig Med Dosw; 1982; 36(1-3):95-131. PubMed ID: 6763997
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted cellular immunotherapy with bifunctional antibodies.
    Nelson H
    Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.
    Whiteside TL; Chikamatsu K; Nagashima S; Okada K
    Anticancer Res; 1996; 16(4C):2357-64. PubMed ID: 8816835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.